May 10, 2023 Experience Livent $10.6 billion merger of equals with Allkem We are advising Livent on the transaction
May 10, 2023 Experience General Motors Financial $400 million senior notes offering The investment-grade notes are due 2026
May 9, 2023 Experience ACELYRIN $621 million IPO The stock is listed on the Nasdaq Global Select Market
May 8, 2023 Experience Kenvue $4.37 billion IPO The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
May 5, 2023 Experience DexCom $1.25 billion convertible notes offering and capped call transactions The 0.375% convertible senior notes are due 2028
May 4, 2023 Experience Ocado Group acquisition of 6 River Systems We are advising Ocado Group on the transaction
May 3, 2023 Experience Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen We are advising Cellular Biomedicine Group on the transaction
May 3, 2023 Experience Advent International $2.25 billion Maxar Technologies acquisition financing We advised the lenders on the facilities
May 3, 2023 Experience Anglo American $900 million notes offering The 5.500% senior notes are due 2033
May 3, 2023 Experience Meta Platforms $8.5 billion senior notes offering We advised Meta on the investment-grade debt offering